近日，爱科百发宣布已正式向香港交易所递交上市申请，计划在港交所主板挂牌上市。此次IPO由多家国际投行联合承销，标志着公司在资本市场的进一步布局。招股书显示，爱科百发是一家专注于生物医药研发的企业，近年来在抗病毒及抗肿瘤领域取得多项突破性进展。公司表示，募集资金将主要用于核心产品的临床研究及商业化推进。港交所文件显示，爱科百发此次上市申请状态为“处理中”，后续进展将依据港交所相关流程推进。
Source Link近日，爱科百发宣布已正式向香港交易所递交上市申请，计划在港交所主板挂牌上市。此次IPO由多家国际投行联合承销，标志着公司在资本市场的进一步布局。招股书显示，爱科百发是一家专注于生物医药研发的企业，近年来在抗病毒及抗肿瘤领域取得多项突破性进展。公司表示，募集资金将主要用于核心产品的临床研究及商业化推进。港交所文件显示，爱科百发此次上市申请状态为“处理中”，后续进展将依据港交所相关流程推进。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.